109 related articles for article (PubMed ID: 6331480)
1. The influence of naloxone on the circulatory effects of captopril.
Rubin PC; Millar JA; Sturani S; Lawrie C; Reid JL
Br J Clin Pharmacol; 1984 Jun; 17(6):713-7. PubMed ID: 6331480
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the antihypertensive effect of captopril by the opioid receptor antagonist naloxone.
Millar JA; Sturani A; Rubin PC; Lawrie C; Reid JL
Clin Exp Pharmacol Physiol; 1983; 10(3):253-9. PubMed ID: 6354530
[TBL] [Abstract][Full Text] [Related]
3. Effect of naloxone on the actions of captopril.
Ajayi AA; Campbell BC; Rubin PC; Reid JL
Clin Pharmacol Ther; 1985 Nov; 38(5):560-5. PubMed ID: 2996820
[TBL] [Abstract][Full Text] [Related]
4. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
Shepherd AN; Campbell BC; Reid JL
J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system and opioids during acute hemorrhage in conscious rabbits.
Schadt JC; Gaddis RR
Am J Physiol; 1990 Feb; 258(2 Pt 2):R543-51. PubMed ID: 2155547
[TBL] [Abstract][Full Text] [Related]
6. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
[TBL] [Abstract][Full Text] [Related]
7. The influence of captopril and naloxone on the Valsalva manoeuvre and systolic time intervals in healthy volunteers.
Richter JP; Sommers DK; Snyman JR
Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):301-5. PubMed ID: 7923895
[TBL] [Abstract][Full Text] [Related]
8. Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog.
Montastruc JL; Gaillard-Plaza G; Montastruc P
Clin Exp Hypertens A; 1984; 6(10-11):1825-8. PubMed ID: 6398140
[TBL] [Abstract][Full Text] [Related]
9. Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.
Ferguson RK; Vlasses PH; Koffer H; Clementi RA; Koplin JR; Willcox CM
Pharmacotherapy; 1983; 3(2 Pt 1):125-30. PubMed ID: 6344035
[TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma renin activity and hypotensive effect of captopril in dogs.
Hamed AT; Lokhandwala MF; Buckley JP; Jandhyala BS
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):195-204. PubMed ID: 6994184
[TBL] [Abstract][Full Text] [Related]
11. Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.
Bernini GP; Lucarini AR; Vivaldi MS; Del Corso C; Lenzi M; Salvetti A
Cardiovasc Drugs Ther; 1989 Dec; 3(6):829-33. PubMed ID: 2487544
[TBL] [Abstract][Full Text] [Related]
12. Effect of captopril, an inhibitor of the converting enzyme on naloxone induced secretion of ACTH and LH in man.
Palermo M; Oliva O; Pala A; Delitala G
Horm Metab Res; 1993 Oct; 25(10):536-8. PubMed ID: 8262463
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies with captopril treatment of hypertensive patients.
Varga K; Alföldi S; Kiss I; Simkó K; Farsang C
Acta Physiol Hung; 1988; 72 Suppl():67-78. PubMed ID: 2855293
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
Lang CC; Stein CM; He HB; Wood AJ
Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
[TBL] [Abstract][Full Text] [Related]
15. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses of conscious DOCA-salt hypertensive rats to acute intracerebroventricular and intravenous administration of captopril.
Pochiero M; Nicoletta P; Losi E; Bianchi A; Caputi AP
Pharmacol Res Commun; 1983 Feb; 15(2):173-82. PubMed ID: 6342005
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.
Boomsma F; de Bruyn JH; Derkx FH; Schalekamp MA
Clin Sci (Lond); 1981 May; 60(5):491-8. PubMed ID: 6265138
[No Abstract] [Full Text] [Related]
18. Role of norepinephrine in the lack of reflex tachycardia after angiotensin converting enzyme inhibitor treatment.
Yagi A; Ichikawa S; Sakamaki T; Ono Z; Sato K; Nakamura T; Murata K
Tohoku J Exp Med; 1992 Apr; 166(4):429-37. PubMed ID: 1502689
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of epinephrine in the cardiovascular effect of naloxone in humans.
Hernandez J; Pérez-Ojeda E; Serrano JS; Castillo JR; Serrano MI
Clin Ther; 1985; 7(4):418-23. PubMed ID: 4016825
[TBL] [Abstract][Full Text] [Related]
20. Naloxone reversal of hypotension due to captopril overdose.
Varon J; Duncan SR
Ann Emerg Med; 1991 Oct; 20(10):1125-7. PubMed ID: 1928887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
